Design and Preclinical Development of TransCon PTH, an Investigational Sustained-Release PTH Replacement Therapy for Hypoparathyroidism

Holten-Andersen, L; Pihl, S; Rasmussen, CE; Zettler, J; Maitro, G; Baron, J; Heinig, S; Hoffmann, E; Wegge, T; Krusch, M; Faltinger, F; Killian, S; Sprogoe, K; Karpf, DB; Breinholt, VM; Cleemann, F

Rasmussen, CE (reprint author), Ascendis Pharma AS, Tuborg Blvd 12, DK-2900 Hellerup, Denmark.

JOURNAL OF BONE AND MINERAL RESEARCH, 2019; 34 (11): 2075

Abstract

Hypoparathyroidism (HP) is a condition of parathyroid hormone (PTH) deficiency leading to abnormal calcium and phosphate metabolism. The mainstay of t......

Full Text Link